<resource xmlns:datacite="http://datacite.org/schema/kernel-4">
<creators>
<creator>
<creatorName>Bartsch, Silvester J. (Medical University of Vienna)</creatorName>
<givenName>Silvester J.</givenName>
<familyName>Bartsch</familyName>
</creator>
<creator>
<creatorName>Pinker, Katja (Memorial Sloan Kettering Cancer Center)</creatorName>
<givenName>Katja</givenName>
<familyName>Pinker</familyName>
</creator>
<creator>
<creatorName>Helbich, Thomas H. (Medical University of Vienna)</creatorName>
<givenName>Thomas H.</givenName>
<familyName>Helbich</familyName>
</creator>
<creator>
<creatorName>Laimer-Gruber, Daniela (Medical University of Vienna)</creatorName>
<givenName>Daniela</givenName>
<familyName>Laimer-Gruber</familyName>
</creator>
<creator>
<creatorName>Kenner, Lukas (University of Veterinary Medicine Vienna / Medical University of Vienna)</creatorName>
<givenName>Lukas</givenName>
<familyName>Kenner</familyName>
</creator>
<creator>
<creatorName>Fürböck, Christoph (Medical University of Vienna)</creatorName>
<givenName>Christoph</givenName>
<familyName>Fürböck</familyName>
</creator>
<creator>
<creatorName>Friske, Joachim (Medical University of Vienna)</creatorName>
<givenName>Joachim</givenName>
<familyName>Friske</familyName>
</creator>
<creator>
<creatorName>Brožová, Klára (University of Veterinary Medicine Vienna / Medical University of Vienna)</creatorName>
<givenName>Klára</givenName>
<familyName>Brožová</familyName>
</creator>
<creator>
<creatorName>Ehret, Viktoria (Medical University of Vienna)</creatorName>
<givenName>Viktoria</givenName>
<familyName>Ehret</familyName>
</creator>
</creators>
<titles>
<title>Non-Contrast-Enhanced Multiparametric MRI of the Hypoxic Tumor Microenvironment Allows Molecular Subtyping of Breast Cancer: A Pilot Study</title>
</titles>
<publisher>MDPI</publisher>
<publicationYear>2024</publicationYear>
<descriptions>
<description descriptionType="Other">Tumor neoangiogenesis is an important hallmark of cancer progression, triggered by alternating selective pressures from the hypoxic tumor microenvironment. Non-invasive, non-contrast-enhanced multiparametric MRI combining blood-oxygen-level-dependent (BOLD) MRI, which depicts blood oxygen saturation, and intravoxel-incoherent-motion (IVIM) MRI, which captures intravascular and extravascular diffusion, can provide insights into tumor oxygenation and neovascularization simultaneously. Our objective was to identify imaging markers that can predict hypoxia-induced angiogenesis and to validate our findings using multiplexed immunohistochemical analyses. We present an in vivo study involving 36 female athymic nude mice inoculated with luminal A, Her2+, and triple-negative breast cancer cells. We used a high-field 9.4-tesla MRI system for imaging and subsequently analyzed the tumors using multiplex immunohistochemistry for CD-31, PDGFR-β, and Hif1-α. We found that the hyperoxic-BOLD-MRI-derived parameter ΔR2* discriminated luminal A from Her2+ and triple-negative breast cancers, while the IVIM-derived parameter fIVIM discriminated luminal A and Her2+ from triple-negative breast cancers. A comprehensive analysis using principal-component analysis of both multiparametric MRI- and mpIHC-derived data highlighted the differences between triple-negative and luminal A breast cancers. We conclude that multiparametric MRI combining hyperoxic BOLD MRI and IVIM MRI, without the need for contrast agents, offers promising non-invasive markers for evaluating hypoxia-induced angiogenesis.</description>
</descriptions>
<resourceType resourceTypeGeneral="Text">PDFDocument</resourceType>
<language>en</language>
<dates>
<date dateType="Created">2024-06-06T09:33:55.711Z</date>
</dates>
<subjects>
<subject>Angiogenesis; Hallmarks; Diffusion; Expression; Pericytes; Receptor; Benign; Hif-1</subject>
</subjects>
<sizes>
<size>709340 b</size>
</sizes>
<formats>
<format>application/pdf</format>
</formats>
<rightsList>
<rights rightsURI="http://creativecommons.org/licenses/by/4.0/">CC BY 4.0 International</rights>
</rightsList>
</resource>
